Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults.

The European respiratory journal·2026

Same author

Impact of 1- and 2-unit red blood cell transfusions on continuously monitored vital signs: a longitudinal study.

Blood transfusion = Trasfusione del sangue·2026

Same author

Risk Groups for Vaccine-Preventable Respiratory Infections in Children and Adults: An Overview of the Australian Environment.

Vaccines·2025

Same author

Remote Continuous Vital Sign Monitoring of Scoliosis Surgery Patients on General Wards: A Cost-Effectiveness Analysis.

Anesthesia and analgesia·2025

Same author

Redrawing the map for corticosteroids in severe community-acquired pneumonia.

European journal of internal medicine·2025

Same author

Using the 2024 National Academies of Science, Engineering, and Medicine Definition of Long COVID: Implications for Pulmonary and Critical Care Medicine.

American journal of respiratory and critical care medicine·2025

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Improving outcomes from community-acquired pneumonia.

Grant Waterer¹, Lesley Bennett

¹aUniversity of Western Australia, Perth, WA, Australia bNorthwestern University, Chicago, Illinois, USA cRoyal Perth Hospital, Perth, Western Australia, Australia.

Current Opinion in Pulmonary Medicine

|March 13, 2015

Summary

Physicians should compare community-acquired pneumonia (CAP) outcomes to improve patient care. A bundle of care, including rapid antibiotics and early mobilization, is recommended for better results.

More Related Videos

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Related Experiment Videos

Last Updated: Apr 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Area of Science:

Healthcare quality improvement
Clinical outcomes research
Infectious disease management

Background:

Public reporting of clinical outcomes is increasing.
Quality of care for community-acquired pneumonia (CAP) requires focused attention.
Individual clinician performance metrics are becoming more prevalent.

Purpose of the Study:

To review the quality of care for CAP patients.
To identify optimal outcome measures and data requirements.
To recommend evidence-based care bundles for improved CAP outcomes.

Main Methods:

Literature review of current evidence on CAP quality of care.
Analysis of outcome reporting and data quality in pneumonia care.
Synthesis of recommended interventions for favorable patient outcomes.

Main Results:

Pneumonia outcomes, especially mortality, have improved over the last decade.
Current quality targets for CAP may be oversimplified.
A comprehensive bundle of care is necessary for optimal outcomes, similar to sepsis management.
Data quality for outcome comparison needs substantial improvement.

Conclusions:

Physicians must actively compare outcomes against peers, not rely on historical data.
A care bundle including rapid antibiotic administration, combination therapy with macrolides, and early mobilization is a recommended starting point.
Improving data quality is crucial for accurate outcome assessment and benchmarking.